Duke Industry Statistics Symposium Postponed until August 26-28

Recent Updates

Jan. 10, 2020

Update: Given the evolving public concerns regarding COVID 19 and the potential travel uncertainties the leadership team has decided to postpone the annual Symposium until August 26-28.

Registration is now open to sign up for the Annual Duke Industry Statistics Symposium.  This year's theme is: "Emerging Clinical Initiatives in Plarmaceutical Development.” 

The Annual Duke Industry Statistics Symposium (DISS) will be held on April 1, 2 and 3 and is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, and co-sponsored by Amgen, ASA-NC Chapter, Boehringer-Ingelheim, ICSA, IQVIA, Janssen, Journal of Biopharmaceutical Statistics, Lilly, PAREXEL, PPD, SAS, UCB and ViiV.  It was established 7 years ago to discuss challenging issues and recent advances related to the clinical development of drugs and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.

The schedule will begin with eight short courses on the first day.  Short courses include: Data Monitoring Committee I and II; Multiple Endpoints; Reproducible Computation at Scale in R; Randomized Phase II Trials, Multiple Endpoints; Adaptive Designs and Articial Intelligence in Health Research.    

The next day (April 2) will begin with a keynote by ShaAvhrée Buckman-Garner, MD, PhD, FAAP, Director of the Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration.  On Friday morning, David Page, PhD, Chairman of the Department of Biostatistics and Bioinformatics will give a keynote followed by the remainder of the parallel scientific sessions. A poster session will be held on Thursday and a Job Fair will be held Friday afternoon.  To learn more, please visit the DISS Event Site.

 Register now!